Work

Supplementary Table S2 from A Pilot Study of Neoadjuvant Nivolumab, Ipilimumab, and Intralesional Oncolytic Virotherapy for HER2-negative Breast Cancer

Year: 2023

Type: supplementary-materials

Abstract: Summary of antibodies, antigen retrieval conditions, incubation conditions, and opal dye labeling for multiplex immunofluorescence experiments

DOI: 10.1158/2767-9764.24018709.v1

Authors: Vina P. Nguyen, Katie M. Campbell, Theodore S. Nowicki, Nila Elumalai, Egmidio Medina, Ignacio Baselga-Carretero, Maggie L. DiNome, Helena R. Chang, Denise K. Oseguera, Antoni Ribas, John A. Glaspy

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4386091492

Cites:

Cited by:

Related to: 10